Ku80 is highly expressed in lung adenocarcinoma and promotes cisplatin resistance

BackgroundKu80 is crucially implicated in DNA repair, apoptosis, and chemoresistance. In this study, we aimed to assess the expression of Ku80 in clinical lung adenocarcinoma specimens, and investigate its role in the regulation of cisplatin sensitivity in cisplatin resistant human lung adenocarcinoma cells A549/DDP.MethodsTumor specimens and medical records of 106 patients with operable lung adenocarcinoma were obtained from 1998 to 2003. Ku80 mRNA and protein levels of the tumor samples, cultured human lung adenocarcinoma cells A549 cells and their cisplatin resistant variant A549/DDP cells were examined by reverse transcription PCR and western blot analysis. Ku80-specific siRNA or control scramble siRNA was transfected into A549/DDP cells, then cell sensitivity to cisplatin was examined by 3-(4,5-dimethylthia-zol-2-yl)-2,5-diphenyltetrazolium bromide assay and apoptosis was assessed by flow cytometric analysis. In addition, the levels of cleaved caspase-3 and cleaved PARP in the treated cells were detected by western blot analysis.ResultsTotal 83.3% (20/24) cisplatin-resistant tumors had high Ku80 expression, while 8.3% (4/48) cisplatin-sensitive tumors had high Ku80 expression (p < 0.01). Univariate analysis indicated that overall survival and progression-free survival were significantly better in lung adenocarcinoma patients with low vs. high Ku80 expression level (p < 0.01). Ku80 mRNA and protein expression levels were significantly increased in A549/DDP cells compared to parental A549 cells. siRNA mediated knockdown of Ku80 resensitized A549/DDP cells to cisplatin-induced apoptosis.ConclusionsKu80 expression level could predict the outcome and the sensitivity to cisplatin-based chemotherapy in patients with lung adenocarcima. Ku80-siRNA could be utilized as a therapeutic strategy to resensitize nonresponders to cisplatin.

• Publication year

  2012

• Venue

  Journal of experimental & clinical cancer research : CR

• Publication date

  2012-11-27

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1186/1756-9966-31-99PMID 23181744PMCID 3527197
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• an update on

  2014cited by this paper
• Ku80 is highly expressed in lung adenocarcinoma and promotes cisplatin resistance

  2012cited by this paper
• Differential Expression of RBM5, EGFR and KRAS mRNA and protein in non-small cell lung cancer tissues

  2012cited by this paper
• Fibroblast growth factor receptor 4 gene (FGFR4) 388Arg allele predicts prolonged survival and platinum sensitivity in advanced ovarian cancer

  2012cited by this paper
• The 3p21.3 tumor suppressor RBM5 resensitizes cisplatin-resistant human non-small cell lung cancer cells to cisplatin.

  2012cited by this paper
• Global cancer statistics

  2011cited by this paper
• Ku80 Is Differentially Expressed in Human Lung Carcinomas and Upregulated in Response to Irradiation in Mice

  2011cited by this paper
• The changing pathology of lung cancer.

  2011cited by this paper
• Role of Ku80-dependent end-joining in delayed genomic instability in mammalian cells surviving ionizing radiation.

  2010cited by this paper
• [The new TNM classification in lung cancer].

  2010cited by this paper
• APE1 overexpression is associated with cisplatin resistance in non-small cell lung cancer and targeted inhibition of APE1 enhances the activity of cisplatin in A549 cells.

  2009cited by this paper
• American Society of Clinical Oncology Clinical Practice Guideline update on chemotherapy for stage IV non-small-cell lung cancer.

  2009cited by this paper
• Significant association of DNA repair gene Ku80 genotypes with breast cancer susceptibility in Taiwan.

  2009cited by this paper
• Ectopic endometrium in human foetuses is a common event and sustains the theory of müllerianosis in the pathogenesis of endometriosis, a disease that predisposes to cancer

  2009cited by this paper
• Ku80 removal from DNA through double strand break–induced ubiquitylation

  2008cited by this paper
• Prognostic significance of ataxia‐telangiectasia mutated, DNA‐dependent protein kinase catalytic subunit, and Ku heterodimeric regulatory complex 86‐kD subunit expression in patients with nonsmall cell lung cancer

  2008cited by this paper
• Mechanisms of resistance to cisplatin and carboplatin.

  2007cited by this paper
• Enhanced repair of DNA interstrand crosslinking in ovarian cancer cells from patients following treatment with platinum-based chemotherapy

  2007cited by this paper
• The resurgence of platinum-based cancer chemotherapy

  2007influential reference
• The biology of Ku and its potential oncogenic role in cancer.

  2006cited by this paper
• Ku80 autoantigen as a cellular coreceptor for human parvovirus B19 infection.

  2005cited by this paper
• [World Health Organization classification of tumours, pathology and genetics of tumours of the lung].

  2005cited by this paper
• Oncogenic H-Ras up-regulates expression of Ku80 to protect cells from gamma-ray irradiation in NIH3T3 cells.

  2005cited by this paper
• Cisplatin: mode of cytotoxic action and molecular basis of resistance

  2003cited by this paper
• Poly(ADP-ribose) polymerase-1 cleavage during apoptosis: An update

  2002cited by this paper
• Ku86 is essential in human somatic cells

  2002cited by this paper
• Apoptosis A Link between Cancer Genetics and Chemotherapy

  2002cited by this paper
• Tumor specific modulation of KU70/80 DNA binding activity in breast and bladder human tumor biopsies

  2001cited by this paper
• Twenty-two years of phase III trials for patients with advanced non-small-cell lung cancer: sobering results.

  2001cited by this paper
• [New guidelines to evaluate the response to treatment in solid tumors].

  2000cited by this paper
• New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada.

  2000cited by this paper
• Cross-resistance to ionizing radiation in a murine leukemic cell line resistant to cis-dichlorodiammineplatinum(II): role of Ku autoantigen.

  1999cited by this paper
• UV sensitivity and impaired nucleotide excision repair in DNA-dependent protein kinase mutant cells.

  1998cited by this paper

• Conversion of Ku80 K568 crotonylation to SUMOylation facilitates DNA non-homologous end joining and cancer radioresistance

  2025cites this paper
• Multifunctional nanoparticle-mediated targeting of metabolic reprogramming and DNA damage response pathways to treat drug-resistant triple-negative breast cancer.

  2025cites this paper
• Techniques to study chimerism at the tissue level in humanized mice.

  2025cites this paper
• BCL11B promotes T‐cell acute lymphoblastic leukaemia cell survival via the XRCC5/C11ORF21 axis

  2024cites this paper
• Combined effects of carbon ion radiation and PARP inhibitor on non-small cell lung carcinoma cells: Insights into DNA repair pathways and cell death mechanisms.

  2024cites this paper
• Peptide L1H9 derived from the interaction of structural human rhomboid family 1 and 80-kDa subunit of Ku antigen sensitizes breast cancer to chemoradiotherapy

  2023cites this paper
• Kaempferol inhibits non-homologous end joining repair via regulating Ku80 stability in glioma cancer.

  2023cites this paper
• A novel DNA damage repair-related signature for predicting prognositc and treatment response in non-small lung cancer

  2022cites this paper
• Identification of key genes and pathways at the downstream of S100PBP in pancreatic cancer cells by integrated bioinformatical analysis

  2021cites this paper
• Elevated XRCC5 expression level can promote temozolomide resistance and predict poor prognosis in glioblastoma

  2021cites this paper
• Targeting RNF8 effectively reverses cisplatin and doxorubicin resistance in endometrial cancer.

  2021cites this paper
• The NRF2-dependent transcriptional axis, XRCC5/hTERT drives tumor progression and 5-Fu insensitivity in hepatocellular carcinoma

  2021cites this paper
• Chemoproteomic Profiling by Cysteine Fluoroalkylation Reveals Myrocin G as an Inhibitor of the Nonhomologous End Joining DNA Repair Pathway.

  2021cites this paper
• Chemoproteomic Profiling by Cysteine Fluoroalkylation Reveals the DNA Repair Protein XRCC5 as a Functional Target of Myrocin G

  2021cites this paper
• Gene expression and prognosis of x-ray repair cross-complementing family members in non-small cell lung cancer

  2021cites this paper
• The Ku complex: recent advances and emerging roles outside of non-homologous end-joining

  2021cites this paper
• Proteomic analyses reveal divergent ubiquitylation patterns in hepatocellula carcinoma cell lines with different metastasis potential.

  2020cites this paper
• Molecular Carcinogenesis

  2020cites this paper
• DNA-PK in human malignant disorders: Mechanisms and implications for pharmacological interventions.

  2020cites this paper
• Integration of survival and binary data for variable selection and prediction: a Bayesian approach

  2019cites this paper
• Transcriptional landscape of DNA repair genes underpins a pan-cancer prognostic signature associated with cell cycle dysregulation and tumor hypoxia

  2019cites this paper
• Overexpression of CLC-3 is regulated by XRCC5 and is a poor prognostic biomarker for gastric cancer

  2018cites this paper
• Clinical values of Ku80 upregulation in superficial esophageal squamous cell carcinoma

  2018cites this paper
• Ku80 correlates with neoadjuvant chemotherapy resistance in human lung adenocarcinoma, but reduces cisplatin/pemetrexed-induced apoptosis in A549 cells

  2017influential citation
• Effect of Ku80 on the radiosensitization of cisplatin in the cervical carcinoma cell line HeLa

  2017cites this paper
• Expression of CXCR4 and VEGF‐C is correlated with lymph node metastasis in non‐small cell lung cancer

  2017cites this paper
• MDM2 binding protein as a predictor of metastasis and a novel prognostic biomarker in patients with gastric cancer

  2017cites this paper
• The Role of the Core Non-Homologous End Joining Factors in Carcinogenesis and Cancer

  2017cites this paper
• XRCC5 cooperates with p300 to promote cyclooxygenase-2 expression and tumor growth in colon cancers

  2017cites this paper
• Synergistic therapy of chemotherapeutic drugs and MTH1 inhibitors using a pH-sensitive polymeric delivery system for oral squamous cell carcinoma.

  2017cites this paper
• Hsa-miR-623 suppresses tumor progression in human lung adenocarcinoma

  2016cites this paper
• Correction to: Hsa-miR-623 suppresses tumor progression in human lung adenocarcinoma

  2016cites this paper
• Expression and significance of Ku80 and PDGFR-α in nasal NK/T-cell lymphoma.

  2016cites this paper
• Overexpression of Ku80 Suggests Poor Prognosis of Locally Advanced Esophageal Squamous Cell Carcinoma Patients

  2015cites this paper
• Postoperative Radiotherapy Improves Survival in Stage pT2N0M0 Esophageal Squamous Cell Carcinoma with High Risk of Poor Prognosis

  2015cites this paper
• Clinicopathological and prognostic significance of metastasis-associated protein 1 expression and its correlation with angiogenesis in lung invasive adenocarcinomas, based on the 2011 IASLC/ATS/ERS classification

  2015cites this paper
• Overexpression of Ku80 correlates with aggressive clinicopathological features and adverse prognosis in esophageal squamous cell carcinoma

  2015cites this paper
• Prognostic significance of Ku80 in pT2N0M0 esophageal squamous cell carcinoma after Ivor-Lewis esophagectomy

  2015cites this paper
• By downregulating Ku80, hsa-miR-526b suppresses non-small cell lung cancer

  2014influential citation
• Sequential release of autophagy inhibitor and chemotherapeutic drug with polymeric delivery system for oral squamous cell carcinoma therapy.

  2014cites this paper
• JWA reverses cisplatin resistance via the CK2—XRCC1 pathway in human gastric cancer cells

  2014cites this paper
• 7B7: a novel antibody directed against the Ku70/Ku80 heterodimer blocks invasion in pancreatic and lung cancer cells

  2014cites this paper
• Reversal of multidrug resistance by cisplatin-loaded magnetic Fe3O4 nanoparticles in A549/DDP lung cancer cells in vitro and in vivo

  2013cites this paper
• Cisplatin-induced downregulation of SOX1 increases drug resistance by activating autophagy in non-small cell lung cancer cell.

  2013cites this paper
• Expression of Notch-1 and its clinical significance in different histological subtypes of human lung adenocarcinoma

  2013cites this paper